Brookstone Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $78.4M | Buy |
65,395
+25,186
| +63% | +$25.7M | 0.79% | 23 |
|
|
2026
Q1 | $37M | Sell |
40,209
-1,595
| -4% | -$1.62M | 0.42% | 52 |
|
|
2025
Q4 | $44.9M | Sell |
41,804
-4,521
| -10% | -$4.32M | 0.51% | 38 |
|
|
2025
Q3 | $35.3M | Buy |
46,325
+4,558
| +11% | +$3.39M | 0.42% | 50 |
|
|
2025
Q2 | $32.6M | Buy |
41,767
+5,471
| +15% | +$4.25M | 0.43% | 50 |
|
|
2025
Q1 | $30M | Sell |
36,296
-1,033
| -3% | -$860K | 0.43% | 59 |
|
|
2024
Q4 | $28.8M | Buy |
37,329
+4,300
| +13% | +$3.56M | 0.42% | 61 |
|
|
2024
Q3 | $29.3M | Buy |
33,029
+2,089
| +7% | +$1.88M | 0.43% | 56 |
|
|
2024
Q2 | $28M | Buy |
30,940
+2,558
| +9% | +$2.05M | 0.46% | 50 |
|
|
2024
Q1 | $22.1M | Buy |
28,382
+4,464
| +19% | +$3.18M | 0.39% | 56 |
|
|
2023
Q4 | $13.9M | Buy |
23,918
+1,170
| +5% | +$683K | 0.27% | 101 |
|
|
2023
Q3 | $13.4M | Buy |
22,748
+76
| +0.3% | +$39.2K | 0.3% | 88 |
|
|
2023
Q2 | $10.2M | Sell |
22,672
-399
| -2% | -$167K | 0.21% | 135 |
|
|
2023
Q1 | $8.59M | Sell |
23,071
-2,751
| -11% | -$928K | 0.17% | 142 |
|
|
2022
Q4 | $9.37M | Sell |
25,822
-2,764
| -10% | -$980K | 0.19% | 131 |
|
|
2022
Q3 | $9.28M | Sell |
28,586
-6,948
| -20% | -$2.2M | 0.21% | 121 |
|
|
2022
Q2 | $11.7M | Buy |
35,534
+6,541
| +23% | +$1.96M | 0.26% | 95 |
|
|
2022
Q1 | $8.96M | Buy |
28,993
+1,705
| +6% | +$439K | 0.18% | 117 |
|
|
2021
Q4 | $7.08M | Sell |
27,288
-864
| -3% | -$219K | 0.12% | 146 |
|
|
2021
Q3 | $6.66M | Buy |
28,152
+3,818
| +16% | +$942K | 0.12% | 151 |
|
|
2021
Q2 | $5.73M | Buy |
24,334
+8,140
| +50% | +$1.64M | 0.1% | 170 |
|
|
2021
Q1 | $3.02M | Buy |
16,194
+1,759
| +12% | +$344K | 0.12% | 150 |
|
|
2020
Q4 | $2.44M | Buy |
14,435
+1,184
| +9% | +$177K | 0.1% | 162 |
|
|
2020
Q3 | $1.96M | Buy |
13,251
+1,693
| +15% | +$262K | 0.09% | 148 |
|
|
2020
Q2 | $1.9M | Sell |
11,558
-187
| -2% | -$28.7K | 0.12% | 123 |
|
|
2020
Q1 | $1.63M | Buy |
11,745
+132
| +1% | +$18.1K | 0.09% | 128 |
|
|
2019
Q4 | $1.53M | Buy |
11,613
+396
| +4% | +$45.9K | 0.08% | 138 |
|
|
2019
Q3 | $1.25M | Buy |
11,217
+281
| +3% | +$31.3K | 0.07% | 155 |
|
|
2019
Q2 | $1.21M | Buy |
10,936
+658
| +6% | +$77.5K | 0.07% | 176 |
|
|
2019
Q1 | $1.33M | Sell |
10,278
-258
| -2% | -$31.4K | 0.09% | 124 |
|
|
2018
Q4 | $1.22M | Sell |
10,536
-44,403
| -81% | -$4.96M | 0.09% | 117 |
|
|
2018
Q3 | $5.89M | Sell |
54,939
-12,836
| -19% | -$1.28M | 0.45% | 49 |
|
|
2018
Q2 | $5.78M | Sell |
67,775
-8,859
| -12% | -$728K | 0.5% | 47 |
|
|
2018
Q1 | $5.93M | Buy |
76,634
+66,194
| +634% | +$5.33M | 0.54% | 46 |
|
|
2017
Q4 | $882K | Sell |
10,440
-66,244
| -86% | -$5.64M | 0.08% | 153 |
|
|
2017
Q3 | $6.56M | Sell |
76,684
-4,455
| -5% | -$365K | 0.59% | 48 |
|
|
2017
Q2 | $6.68M | Sell |
81,139
-377
| -0.5% | -$30.8K | 0.64% | 48 |
|
|
2017
Q1 | $6.86M | Buy |
81,516
+4,195
| +5% | +$336K | 0.69% | 47 |
|
|
2016
Q4 | $5.69M | Buy |
77,321
+67,352
| +676% | +$5.02M | 0.62% | 52 |
|
|
2016
Q3 | $800K | Buy |
9,969
+9
| +0.1% | +$720 | 0.09% | 146 |
|
|
2016
Q2 | $784K | Buy |
9,960
+205
| +2% | +$15.4K | 0.1% | 139 |
|
|
2016
Q1 | $703K | Buy |
9,755
+101
| +1% | +$7.64K | 0.11% | 140 |
|
|
2015
Q4 | $813K | Sell |
9,654
-108
| -1% | -$8.96K | 0.16% | 56 |
|
|
2015
Q3 | $817K | Sell |
9,762
-42,217
| -81% | -$3.56M | 0.15% | 49 |
|
|
2015
Q2 | $4.34M | Buy |
51,979
+8,284
| +19% | +$631K | 0.55% | 21 |
|
|
2015
Q1 | $3.17M | Buy |
43,695
+11,335
| +35% | +$807K | 0.48% | 29 |
|
|
2014
Q4 | $2.23M | Buy |
32,360
+15,050
| +87% | +$1.02M | 0.37% | 30 |
|
|
2014
Q3 | $1.12M | Buy |
17,310
+7,430
| +75% | +$470K | 0.21% | 43 |
|
|
2014
Q2 | $614K | Buy |
9,880
+87
| +0.9% | +$5.19K | 0.13% | 57 |
|
|
2014
Q1 | $576K | Sell |
9,793
-122
| -1% | -$6.81K | 0.15% | 55 |
|
|
2013
Q4 | $506K | Buy |
+9,915
| New | +$497K | 0.15% | 59 |
|
Other funds holding LLY
SC
ONB
GIM
Brookstone Capital Management's LLY Position: Q2 2026 in Review
Brookstone Capital Management increased its Eli Lilly (LLY) stake by 63% in Q2 2026, buying an estimated $25.7M and bringing the position to 65,395 shares worth $78.4M. The position accounts for 0.79% of the portfolio, ranked #23.
Brookstone Capital Management first reported a position in LLY in Q4 2013 and has held it in 51 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Brookstone Capital Management held 65,395 shares of Eli Lilly worth $78.4M as of Q2 2026.
- Brookstone Capital Management bought 25,186 Eli Lilly shares in Q2 2026, an estimated $25.7M.
- Eli Lilly made up 0.79% of Brookstone Capital Management's portfolio in Q2 2026, its #23 holding.
- Brookstone Capital Management first reported a position in Eli Lilly in Q4 2013 and has held it in 51 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.